Synthesis of Therapeutic Agents The two chains of insulin can be separated by detaching it from β-galactosidase using protease peptidase cyanogen bromide hydrogen chloride protease peptidase cyanogen bromide hydrogen chloride ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents How is human insulin synthesized using recombinant DNA technology? By using cDNA for insulin By isolating DNA from the islets of Langerhans of pancreas By using chemically synthesized DNA sequences for the two chains separately By using chemically synthesized DNA sequences for the complete insulin protein By using cDNA for insulin By isolating DNA from the islets of Langerhans of pancreas By using chemically synthesized DNA sequences for the two chains separately By using chemically synthesized DNA sequences for the complete insulin protein ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The first therapeutic product formed by means of recombinant DNA technology is insulin vaccine for foot and mouth disease hepatitis B vaccine human growth hormone insulin vaccine for foot and mouth disease hepatitis B vaccine human growth hormone ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Chemically synthesized DNA sequences for the two chains are separately inserted into the plasmid pBR 322 by the side of β-Galactosidase acid phosphatase glucokinase galactokinase β-Galactosidase acid phosphatase glucokinase galactokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is alcohol dehydrogenase 1 galactokinase β-galactosidase polyhedrin alcohol dehydrogenase 1 galactokinase β-galactosidase polyhedrin ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The recombinant hGH lacks terminal methionine terminal lysine terminal glutamine terminal arginine terminal methionine terminal lysine terminal glutamine terminal arginine ANSWER DOWNLOAD EXAMIANS APP